The line between delivery robots and hospital robots just got blurrier — and the result could accelerate autonomous robot deployment in healthcare settings across Texas and beyond.
Serve Robotics completed its $29 million acquisition of Diligent Robotics in late January 2026, merging two of the most commercially proven autonomous robot companies in the United States. The deal combined Serve's sidewalk delivery platform with Diligent's Moxi — an autonomous hospital logistics robot that has quietly become one of the most widely deployed mobile robots in healthcare anywhere in the world.
Who Is Diligent Robotics?
Diligent Robotics is an Austin, Texas company founded in 2017 by Andrea Thomaz and Vivian Chu. Moxi was built specifically for the demanding environment of hospital operations: unpredictable, high-traffic, safety-critical, and resistant to technology that fails or frustrates staff.
Moxi handles non-clinical logistics tasks — fetching supplies from central storage, delivering medications, moving linens and lab samples, transporting equipment between units. These are tasks that consume significant nursing time without adding clinical value. Moxi robots have completed over 1.25 million autonomous deliveries across more than 25 hospital facilities in the U.S. That is not a pilot program — it is a product that works in production.
Texas Medical Center Implications
The Texas Medical Center — the world's largest medical complex, located in Houston — is a natural market for Moxi. TMC member institutions including Houston Methodist, MD Anderson, and Memorial Hermann are large hospital systems with the operational scale, capital, and appetite for technology that makes autonomous logistics investment viable.
With Diligent now part of a publicly traded company reporting 238% quarter-over-quarter revenue growth in Q1 2026, the Moxi platform is better resourced to expand its Texas hospital footprint than it has ever been.
Why This Merger Makes Strategic Sense
At first glance, a sidewalk delivery robot company acquiring a hospital robot company seems like a stretch. But the underlying technical requirements are more similar than they appear: both platforms demand autonomous navigation in unpredictable, human-populated environments; reliable obstacle avoidance; graceful failure modes; and the ability to operate around people who have better things to do than manage robots.
Serve gets a commercial hospital footprint and a proven product. Diligent gets capital, infrastructure, and public company backing. The combined entity covers two of the highest-value autonomous delivery contexts in the economy: last-mile consumer delivery and hospital logistics. For Houston — a city with both a massive medical complex and a growing logistics sector — it is a story worth watching.